Form 4 for REVB REVELATION BIOSCIENCES, INC.
Accepted 2026-01-12 00:00:00 ET · period of report 2026-01-08 · accession 0001193125-26-010642 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-01-12 | 2026-01-08 | REVB | Zygmont Chester Stanley III | CFO | A - Grant | $0.9 | +78.1K | 473.8K | +20% | +$70.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-08 | A | A | 78,145 | $0.9 | 473,790 | I By Trust | — | — | (F1) Restricted Stock Units under the 2021 Equity Incentive Plan. Vests quarterly over two years from the date of grant. (F2) Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee. |